Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Medical Device Startup Investors in France in May 2025

Last updated: May 2025 A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical device startups based in France. We rank investors based on the number of investments they made in Medical device companies from France. We update this investor list every month.

Top 50 Medical Device Startup Investors in France in May 2025

Investor	Medical Device France investments
Bpifrance	21
GO CAPITAL	13
Karista	12
Sofimac Investment Managers	10
Elaia	10
Seventure Partners	10
Kurma Partners	9
IRDI	8
M Capital Partners	8
Sofinnova Partners	8
Crédit Agricole	7
Omnes Capital	6
Idinvest Partners	6
Newfund	6
UI Investissement	5
Finovam Gestion	5
BNP Paribas Développement	5
Angels Santé	5
WiSEED	5
iBionext	5
IRDI SORIDEC Gestion	4
Inserm Transfert Initiative	4
Nord France Amorcage	4
Auriga Partners	4
Crédit Mutuel Innovation	4
Galia Gestion	4
Cap Innov'Est	3
Supernova Invest	3
Pontifax	3
Pays de la Loire Participations	3
Mérieux Equity Partners	3
MACSF	3
Sodero Gestion	3
MD Start	3
AQUITI Gestion	3
Sham Innovation Santé	3
ACG Management	3
Yann Fleureau	3
IXO Private Equity	2
Sudinnova	2
Guillaume Richard	2
BNP Paribas	2
Medevice	2
HCVC	2
Bioam Gestion	2
European Investment Bank	2
Innovacom	2
A Plus Finance	2
Majycc eSanté Invest	2
Norgine Ventures	2

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Investment focus

Software, Information Technology, Health Care
Seed, Funding Round, Series A
France, United States, Switzerland

Portfolio highlights

Lprint — Lprint revolutionise the way PCBs are designed and manufactured, empowering hardware engineers and product development teams. Lprint is a 3D electronic printing system for PCBs, designed to manufacture complex, free-form printed circuit boards (PCBs) in a single step, simplifying the prototyping, testing, and manufacturing process of electronics.
Veesion — Veesion: AI-driven smart video surveillance. Detect theft in real time. Protect your business now.
PyxiScience — PyxiScience operates as an adaptive Math Learning Platform designed by educators and powered by AI.

GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementarysectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future.

Investment focus

Biotechnology, Software, Health Care
Funding Round, Seed, Series A
France, Canada, Israel

Portfolio highlights

AISPRID — AISPRID is a robotic company that manufactures autonomous robots for soft fruit picking.
BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
Moea — MOEA recrute ! Consultez toutes nos offres d'emploi (CDI, CDD) ainsi que toutes nos offres de stage et postulez en ligne.

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Investment focus

Software, Biotechnology, Health Care
Seed, Series A, Series B
France, United States, Finland

Portfolio highlights

Deemea — Deemea is a collaborative AI platform that connects and provides services for the analysis of medical data for physicians. It uses its expertise in clinical research, data science, and software development to help healthcare professionals.
10Lines — 10Lines is developing autonomous parking lot marking robots and technological solutions to significantly increase productivity in the industry of pavement marking. Our solutions are helping striping businesses do their work much more productively with a smaller environmental footprint.
Brightflow — Brightflow operates as a medical device startup.

Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)

Investment focus

Biotechnology, Health Care, Manufacturing
Funding Round, Seed, Series A
France, Italy, Austria

Portfolio highlights

Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.

Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Series B
France, United States, Spain

Portfolio highlights

Hema.to — Hema.to provides fully automated, AI-powered blood cancer detection suggestions based on flow cytometry data.
Alice & Bob — At Alice & Bob, we're building the first universal quantum computer. This is humanity's next challenge.
GetVocal AI — GetVocal AI is help companies automate customer service processes with the most advanced Conversational AI phone agent.

Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy

Investment focus

Biotechnology, Health Care, Software
Series A, Funding Round, Series B
France, United States, Germany

Portfolio highlights

Ekstere — Ekstere facilitates selling and purchasing verified-quality used bicycles at a reasonable price.
Anybuddy — Anybuddy is a sport booking marketplace, leader in racket sport in France
Seaweed Concept — Seaweed Concept is a marine biotechnology company, that focuses on the innovative utilization of seaweed to provide high-quality ingredients to various industrial sectors

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Investment focus

Health Care, Biotechnology, Pharmaceutical
Series A, Seed, Series B
France, Switzerland, Spain

Portfolio highlights

DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
Avidicure — Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer

IRDI Gestion aims to participate in the economic growth and job creation in their regions. For this, their teams create a real partnership with the companies they accompany, based on a relationship of trust and proximity.IRDI Gestion currently manages €150 million and has financial tools able to accompany the Southwest SMEs in the creationphase, development or transmission, with intervention tickets from equity € 100000 to € 5000000.Precursor of regional investment capital of the Southwest, with a presence of over 35 years, the IRDI Group consists of 3 SCR:- IRDI, created in 1981 to foster industrial growth companies based in the South West of France- MPcroissance, created in 1996 to assist small businesses in Midi-Pyrénées- IRDInov, created in 2012 under the leadership of the National Seed Fund (under the PIA) to fund the initiation of innovative companiesIn 2015, the management company IRDI Gestion, approved by the AMF, was formed to structure the group and bring new development projects.

Investment focus

Health Care, Biotechnology, Software
Funding Round, Series A, Series B
France

Portfolio highlights

REEV — REEV motorizes medical orthoses to help millions of people affected by gait disorders to walk, stand, sit and climb stairs with greater ease every day.
Starfish Bioscience — STARFISH Bioscience focuses on the creation and development of microbiological solutions for agriculture and vineyards. Our objective is to regenerate soils by restoring their microbiomes, increasing sustainability and productivity while minimizing environmental impact. We are dedicated to improving humanity's well-being and preserving theearth by inventing technologies that address the future difficulties of global agriculture.
Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.

M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.

Investment focus

Health Care, Software, Food and Beverage
Funding Round, Seed, Series A
France, United States, Canada

Portfolio highlights

Fasst — Fasst is involved in the creation, distribution, consulting, and connection of unique digital insurance solutions for brokers and insurers.
Hakbah — Hakbah is a Fintech startup focusing on an alternative financial saving. Hakbah is modernizing financial saving via its intelligent platform by offering a comprehensive one-stop-shop solution for Savings Groups to initiate, manage, join, and pay directly within the mobile app.
Demether — Demether is a DeFi protocol that works to enable zero-cost access to TVL for blockchains.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.

Credit Agricole is a banking corporation with focuses on corporate and investment banking, retail banking, and savings management. Crédit Agricole Group is a responsible, helpful bank serving 49 million customers, 7.4 million mutual shareholders, and 1.2 million shareholders. Crédit Agricole Group supports its customers in their plans and projectsin France and around the world, through its operations in all segments of the market including insurance, real estate, payment systems, asset management, leasing and factoring, consumer finance, and corporate and investment banking. Crédit Agricole also stands out for its dynamic, innovative corporate social responsibility policy serving the economy. This policy is based on a pragmatic approach that permeates throughout the entire Group and engages all its employees. Its recent inclusion in the Vigeo-NYSE Euronext extra-financial indices is recognition of this engagement.

Investment focus

Software, Manufacturing, Health Care
Funding Round, Seed, Debt Financing
France, United States, Italy

Portfolio highlights

TSE — TSE is a solar energy producer that provides photovoltaic and agrivoltaic solutions.
AdEchoTech — The company was the first to market a robotic tele-ultrasound solution, expanding the capabilities currently offered in the field of teleradiology.
Eduservices — Eduservices network and pool a set of skills and resources for schools.

Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar.

Investment focus

Biotechnology, Software, Health Care
Series A, Funding Round, Series B
France, Germany, United States

Portfolio highlights

Planet A Foods — The chocolate revolution is here. 100% cocoa-free and unbelievably delicious. We call it QOA. You need to try it!
VSORA — VSORA provides high performance companion solutions combining AI and signal processing to enable autonomous driving and ADAS
Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Investment focus

Biotechnology, Health Care, Software
Series B, Series A, Funding Round
France, United States, Spain

Portfolio highlights

Corti — Corti offers a digital assistant, augmenting medics in improving patient outcomes and internal performance.
StarTower — StarTower is a resource company built specifically for fully decentralized physical infrastructure and shared interaction. Based on the exclusive RIP encryption technology, StarTower realizes the interactive sharing of multiple resources with zero loss on mobile devices, thereby providing efficient resource transmission for terminal facilities. Itprovides more efficient, secure and reliable solutions in the fields of Internet of Things, smart cities, industrial automation, healthcare, etc.
Stilla Technologies — Stilla Technologies is taking digital PCR to a whole new level with a unique 6-color target detection capability

Newfund is a $300M entrepreneurial VC firm dedicated to pre-seed and seed investments in France and North America, in companies driving global change. The company is always looking for founders who are driven to realize a vision that will significantly alter the world in which we live. In order to appreciate what entrepreneurs are creating andutilize their strengths, Newfund aims to comprehend entrepreneurs as unique individuals.

Investment focus

Software, Information Technology, SaaS
Seed, Funding Round, Series A
France, United States, Canada

Portfolio highlights

Evera — Olino is the insurance for tomorrow's SME. A digital service, a turnkey solution tailored to VSBs and SMEs, meeting all insurance needs.
Diagnoly — Diagnoly provides AI-powered ultrasound assistant that enhances fetal screenings with real-time analysis, instant insights, and zero workflow disruption.
PyxiScience — PyxiScience operates as an adaptive Math Learning Platform designed by educators and powered by AI.

Since 1967, the UI brand embodies a partnership with companies. Actor of the economy, UI has accompanied more than 120 SMEs over the last fifteen years, investing more than 550m € and giving substance to their development projects. Combining experience and corporate culture, UI has established itself as an involved and independent partner, able tocount on its shareholder leaders to favor, independently, the sustainable performance of the SMEs it accompanies.

Investment focus

Manufacturing, Software, Health Care
Private Equity, Series A, Seed
France, Spain, Canada

Portfolio highlights

DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
Fizimed — Fizimed has made the choice to develop the EMY perineal probe with recognized health professionals. The probe is connected to a mobile app and associated with custom exercises. The probe captures the contractions of the perineal muscles in real time to allow the patient to do 5-minute exercises through fun games (jumping obstacles, jumping ...) sothat she remains motivated. The patient can follow her results as well as her progress in the application and unlock new universes according to the points obtained. Much of the effort of Fizimed's technical teams is focused on balancing a product, combining the quality and safety of a medical device, with a fun application to empower each woman. One goal: the simplicity of the product and the interface for home use.Beyond the product, the Fizimed team is committed to the fight against taboos related to urinary incontinence problems affecting one in ten women. She wants to "demystify" this topic so that every woman can find her adapted solution. An EMY community is being born on social networks in which the feminine hassles are put into images and discussed with humor, while talking about innovations that can simplify their daily lives.In summary, EMY by Fizimed is the connected and fun medical probe that allows women wishing to regain control of their perineum to do their home exercises. It was developed by a dynamic Alsatian start-up whose ambition is to remove taboos on a public health issue.
Nova Carbon — High-performance sustainable carbon fiber composites

Finovam Gestion is an investment company approved by the AMF which takes minority stakes in innovative SMEs with high growth potential.The company, which manages €50M, invests in companies that have developed innovative offers in the following target sectors: Information and Communication Technology, Health and Biotechnologies, Agro-resources andEcotechnologies.Finovam Gestion has built solid relationships with the ecosystem of entrepreneurship (Industrials, Poles of Competitiveness, Incubators, Accelerators, Universities, and Research Centers) in all the sectors that we target in order to be able to source and do emerge the best companies.Among our investors (LPs), we can count BPI France, manufacturers (ADEO, LESAFFRE, TEREOS), banks (BNP Paribas, Caisse d´Epargne, Crédit Agricole) and the Haut de France and Grand-Est regions.

Investment focus

Information Technology, Software, Medical Device
Seed, Funding Round, Series A
France, United States

Portfolio highlights

Nijta — You have tons of speech data but handling it is a compliance minefield. Leverage the power of Nijta's AI-based voice anonymisation to use your data at scale without compromising privacy and confidentiality.
Selvitys — Selvitys is a fully automated method for designing, delivering, and analyzing online surveys.
BiblioOnDemand — BiblioOnDemand is a provider of digital library services that offer a diverse selection of ebooks and audiobooks.

BNP Paribas Développement is the investment arm of BNP Paribas that specializes in SME development. It specializes in second stage, mezzanine, bridge, acquisition, leveraged buyouts, management buyouts, recapitalization, special situations, and privatizations transactions.The firm considers investments in manufacturing, service industries,medicine, electronics, energy, chemistry, new materials, industrial automations, industrial goods and services, transportation, consumer goods, commerce and distribution, buildings and public works, wholesale retail, biotechnology, telecommunications, and information technology sectors.BNP Paribas Développement was established in 1988 and is based in Paris, France.

Investment focus

Software, Information Technology, Health Care
Funding Round, Series A, Seed
France, Germany, The Netherlands

Portfolio highlights

Poppins — Mila merges music, technology, and neuroscience to reshape therapy into a musical experience. We create musical games for children based on neurologic music therapy methods. These games are designed to address learning dissabilities like dyslexia, providing a digital treatment at home and helping identify these conditions. Behind these games, weleverage data science and new technologies to interpret learning, language, and motor performance into a cognitive score. Our goal is to improve the process for patients receiving treatment and to reaching the vast undiagnosed majority.
Eduservices — Eduservices network and pool a set of skills and resources for schools.
Ostrea — OSTREA is a pioneering company in the creation of high-performance materials based on bio-minerals: seashells.

Angels Santé is a networking site for investors and companies in the health sector.

Investment focus

Health Care, Biotechnology, Medical Device
Seed, Funding Round, Angel
France, India, United States

Portfolio highlights

Abcely — Abcely is a biotech firm that is working on a novel anti-cancer medication.
SeaBeLife — SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.
MB Therapeutics — MB Therapeutics is a pharmaceutical firm that provides patient-centric solutions for developing and producing tailored medicines.

Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.

Investment focus

Software, Manufacturing, Biotechnology
Seed, Funding Round, Equity Crowdfunding
France

Portfolio highlights

Leasi — Leasi delivers a forward-thinking rental and resource management system for companies that engage in internal or external distribution of machinery. This is achieved through an ecosystem that emphasizes the excessive use of data and datasharing, with a focus on user experience. Our goal is to create a simpler, more streamlined, and more efficientworkday for industry players by leveraging the power of data and collaboration within the ecosystem to ultimately reduce emissions, increase efficiency and enhance profitability.
Aéronde — The Aéronde is an innovative electric airship with a toroidal shape (giant donut) of 15 meters in diameter, designed to offer a silent, energy-efficient flight with very low environmental impact. Inflated with approximately 400 m³ of helium, it can carry up to two people and equipment, with a payload of 200 kg .
Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.

iBionext is a unique healthcare fund created within a proven breakthrough innovation accelerator. Their companies are based in a single location named “Passage de l’innovation” in Paris, France. Over the past 4 years, we have created 7 companies that have raised over 250M € and created 103 highly qualified jobs.

Investment focus

Medical Device, Artificial Intelligence, Biotechnology
Funding Round, Series A, Seed
France

Portfolio highlights

Prophesee — REVEAL THE INVISIBLE with the world's most advanced neuromorphic vision system, inspired by human vision and built on the foundation of neuromorphic engineering. PROPHESEE gives Metavision to machines, revealing what was previously invisible to them.
GrAI Matter Labs — GrAI Matter Labs has created the fastest edge AI processor for machine vision in robotics, AR/VR, drones and more. It achieves ultra-low latency at low power by leveraging sparsity.
Tilak Healthcare — Tilak is a unique videogame studio where like-minded & passionate people create fun mobile medical games to monitor patients with chronic diseases.

IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.

Investment focus

Software, Biotechnology, Information Technology
Seed, Series A, Funding Round
France, Brazil, Singapore

Portfolio highlights

FEEDAE — Feedae uses AI-augmented dialog analysis to boost sales and customer service teams' performance.
IsyBuy — IsyBuy is a smartphone application that allows to find restaurants and bars that have your way, consult the menu, place order, and still pay your bill directly from your cell phone, with just one click. It's the fastest, easiest, and safest way to borrow and pay. They will never have to wait to be served by a waiter, let alone beg to receivethe account or the card machine.
Keysom — Develops RISC V based processor architectures that are automatically built from the application source code and dynamically reconfigurable.

Inserm Transfert Initiative is a seed stage life science vehicle currently managing about â‚¬4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.

Investment focus

Biotechnology, Medical, Health Care
Series A, Series B, Seed
France, Switzerland, United States

Portfolio highlights

Eyevensys — Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasiveprocedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability.They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.
VectivBio — We Are Ironwood
Aelis Farma — Aelis Farma is a pioneer in the development of signaling specific therapeutics that target GPCRs (and more specifically the CB1 receptor which is one of the most expressed GPCRs in the brain). GPCRs are the target of most therapeutic drugs. This family of receptors has the characteristics to activate several and often opposing signaling pathways.Unfortunately, most of the drugs acting on GPCRs either block or stimulate the entire signaling activity of the receptor resulting in unwanted and sometimes unacceptable side effects.

Nord France Amorçage is a regional co-investment fund, exclusively supported by the Hauts-de-France Region. This seed fund has been involved since 2013 in financing innovative businesses that create jobs and add value to the region. In 6 years, NFA has more than 50 participants spread across the region.

Investment focus

Software, Information Technology, Health Care
Seed, Funding Round, Series A
France, United States

Portfolio highlights

NeoCem — NeoCem creates, manufactures, and promotes a variety of low-carbon cements for the building industry. They have developed a novel procedure that permits the utilization of raw materials sourced from recovery sectors.
Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
Energo — Energo, combines cold plasma with catalysis to produce molecules of interest for the decarbonization of industry, such green hydrogen, biofuels, or synthetic methane from CO2, biogas, and ammonia.

Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
France, United States, Switzerland

Portfolio highlights

Patrowl — Identify and harden your External Security Posture with Patrowl, the leader. Let us manage time-consuming tasks and focus on remediation.
Exeliom — Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs. Their mission is to harness the therapeutic potential of gut microbiota to enable people to lead longer and healthier lives. They are committed to developing the next generation of probiotics: innovative microbial therapies.Exeliom develops anew class of medicines called Live Biotherapeutics based on their growing understanding of the central role of the microbiota in the immune system.The company was founded in 2016 and is headquartered in Dijon, France.
Vade Secure — Vade is a global leader in predictive email defense, protecting 1 billion inboxes worldwide. AI-based email security for Microsoft 365.

Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages.We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders.Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.

Investment focus

Software, Health Care, Biotechnology
Funding Round, Series A, Series B
France, United States, Canada

Portfolio highlights

UroMems — The device is developing an active implantable medical device based on the cutting edge technologyl in the field of embedded systems and micro-technologies for the development of its products.
Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
Planity — Planity, a platform that allows you to book an appointment with a professional in the beauty sector in a few clicks and quickly find a hair salon, beauty institute, barber near you

Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.

Investment focus

Software, Manufacturing, Biotechnology
Funding Round, Series A, Seed
France, United States

Portfolio highlights

Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.

Cap Innov’Est is a 36M€ tri-regional fund dedicated to investments in young innovative start-ups. Cap Innov’Est was launched in July 2014 and has already invested in 13 start-ups. Cap Innov’Est is supported by Fonds National d’Amorçage, the 3 Regions Alsace, Bourgogne and Franche-Comté, SAFIDI, caisses d’épargne d’Alsace etBourgogne/Franche-Comté, BNP Paribas et CIFC

Investment focus

Biotechnology, Pharmaceutical, Health Care
Seed, Series A, Funding Round
France, United States

Portfolio highlights

VistaCare — "Making Difficult Wounds Easy" : VistaCare is a Breakthrough and non-invasive Medical Device designed for treatment during the critical phases of the wound.
Opencell Software — Increase recurring revenue. Opencell's platform simplifies launch, scales with your business, and streamlines billing. Optimize sales cycles, improve customer experience, and gain valuable revenue insights. Start today!
Rhythm Diagnostic Systems — Many of our team have worked together on different projects and in different companies over the last 30-plus years. We are experienced technology, medical, health care and biotech professionals, with long, successful histories in Silicon Valley and elsewhere.

we believe that top scientists and ambitious entrepreneurs can build a world where cutting-edge technologies shape the next generation of industry leaders.

Investment focus

Health Care, Medical Device, Biotechnology
Series A, Funding Round, Seed
France, Switzerland, United States

Portfolio highlights

ANYbotics — ANYbotics provides autonomous legged robots for industrial applications to provide high availability and reliability in automated routine inspections.
Capra Robotics — Our Mobile Robot Platform is a versatile solution optimized for outdoor use in any terrain. Read more about how the CAPRA can work for you.
Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, Israel, France

Portfolio highlights

ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
Lutris Pharma — Improving anti-cancer therapy by reducing dose limiting side effects
Indapta Therapeutics — Indapta Therapeutics is a privately held biotechnology company developing an NK (natural killer) cell therapy platform for the treatment of blood and solid tumor cancers.

Pays de la Loire Participations provides finance innovation, productivity and development, especially in a banking context that is increasingly constrained by standards and regulations.The Pays de la Loire region has created the "Pays de la Loire Participations" co-investment fund (PLP) intended for small and medium-sized companieswishing to strengthen their equity. By investing alongside private professional investors, it facilitates risk taking and helps anchor long-term skills on the territory and promotes job creation and wealth.With 14 million euros in capital (20 million in the long term), entirely contributed by the Region, the "Pays de la Loire Participations" fund co-invested an average of around 2.5 million euros annually. average of € 180 K per company. Its intervention as a co-investor is crucial because it allows the VSE / SME beneficiaries to obtain from private financiers and banks, 4 times the funds contributed by Pays de la Loire participations.

Investment focus

Manufacturing, Software, E-Commerce
Funding Round, Seed, Private Equity
France

Portfolio highlights

VoltR — VoltR is a manufacturing company specializes in restoring lithium batteries.
Tract'Moi — Tract'Moi is a producer of farming equipment for farmers seeking independence and adaptability.
D-ICE Engineering — D-ICE Engineering is a deeptech company that specializes in dynamic positioning, hydrodynamics, marine energy, A-I, and system engineering.

Mérieux Equity Partners (“MxEP”) is a management company dedicated to venture, growth and LBO investments in the healthcare and nutrition sectors. MxEP actively supports entrepreneurs and industrial companies with differentiated products and services, by providing privileged access to its expertise and international network. MxEP currently managesmore than €600m AUM and has recently launched a new vehicle MP3 of €350m dedicated to growth/LBO.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Funding Round, Private Equity
France, United States, Belgium

Portfolio highlights

DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
Ceva Santé Animale — Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. FromUganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.
CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.

Mutuelle d'Assurance du Corps de Santé Français (MACSF) is the provider of insurance to health professionals. MACSF protects and accompanies 950,000 members of all medical and paramedical specialties, offering professional and personal solutions in insurance, savings, financing, and pensions. Its products and services meet the real needs ofits members by accompanying them in the evolution of their profession and their projects.MACSF was founded in 1935.

Investment focus

Health Care, Artificial Intelligence, Medical Device
Series A, Funding Round, Seed
France, Spain, Ecuador

Portfolio highlights

Pixmania — Pixmania is an e-commerce website that provides buying and selling of speakers, cameras, headphones, and mobile devices.
Singulier — Singulier partners with global private equity funds and portfolio companies to accelerate transformation and unlock value.
RDS — RDS is a healthcare technology startup that specializes in remote patient monitoring solutions. The company's primary product, MultiSense®, is designed to help healthcare professionals continuously monitor patients' physiological parameters, whether they're in a hospital or at home. This innovative and multi-patented technology isaimed at improving patient pathways, which in turn enhances the quality of life and care efficiencies. The company's market is primarily hospitals (particularly surgical departments) and institutions that are looking for ways to improve patient care and reduce hospital stays. By facilitating early hospital discharge and continuous monitoring, RDS solution can contribute to significant healthcare savings. The MultiSense® solution is now CE marked (MDR) and is available for sale in several European countries. The company generates recurring revenues by providing the solution on a “fee for a service” business model to healthcare institutions and professionals. The product has been well-received in the market, earning multiple awards and the support of a vibrant community of clinicians. In addition to its primary product, RDS also provides services that help healthcare systems become more attractive and sustainable. This includes training and support for healthcare professionals to effectively use the MultiSense® technology. Keywords: Healthcare Technology, Remote Patient Monitoring, MultiSense®, Patient Pathways, Care Efficiencies, Hospital Discharge, Healthcare Savings, Clinicians, Physiological Parameters, Our main product, MultiSense®, is a comprehensive Remote Patient Monitoring Solution. MultiSense® offers healthcare professionals a high-precision, multi-parametric solution to continuously monitor patients’ physiological parameters in the hospital and beyond. MultiSense® combines a wearable patient monitor designed to capture high-accuracy physiological data with a cloud platform that helps transform these data into actionable clinical insights. MultiSense® is a patented medical device that has received multiple awards. MultiSense® has been validated by 6 completed clinical investigations.RDS relies on a talented and international team with deep subject-matter-expertise and a proven track record in the Healthcare and Medical Device sector. At RDS, we all share the same passion for bringing patient pathways to the next level.

Sodero Management has 70 million of capital it intends to finance for SMEs. These funds come from the Caisse d'Epargne and Caisse des Depots et Consignations, firstly, of Brittany and Pays de la Loire, on the other. But also individuals from which â‚¬ 26m was raised in 5 years through FIP (Local Investment Fund sold each year by the SavingsBank from November). And local savings will directly feed the local economy while enjoying immediate tax benefits.

Investment focus

Software, Information Technology, Telecommunications
Seed, Funding Round, Series A
France

Portfolio highlights

Grimp — Saas solution to manage your job search in one place.
D-ICE Engineering — D-ICE Engineering is a deeptech company that specializes in dynamic positioning, hydrodynamics, marine energy, A-I, and system engineering.
BioMAdvanced Diagnostics — BioMAdvanced Diagnostics is a developer of molecular diagnostic and biomarker tests designed to follow up on the immune response of patients

MD Start is an incubator and fund dedicated to medical technologies. MD Start creates, develops, and operates medical projects, turning them into new companies with both strategic and hands-on approaches, in order to bring them to investment stage and commercial development.

Investment focus

Medical Device, Health Care, Medical
Seed, Series B
France

Portfolio highlights

Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
HEPTA Medical — HEPTA Medical develops a sensor, embedded into a bronchoscopic or percutaneous ablation catheter, which provides temperature-based feedback. This enables real-time dosing to precisely target and ablates pulmonary nodules, the precursor of lung cancer, without the need for surgery or radiation.
Gradient Denervation Technologies — Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension, based on prior research and intellectual property developed at Stanford University.

Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors.Up to now, AQUITI GESTION has invested in more than 200operations contributing to the creation and development of about 150 companies and thousands of jobs.Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.

Investment focus

Biotechnology, Software, Manufacturing
Funding Round, Series A, Seed
France, United States

Portfolio highlights

Speeral — Speeral is a technological solution for user to access second-hand market and products.
Aquassay — Aquassay assists you with improving the industrial and environmental performance of all your water usage (supply, production, discharge).
Materrup — Materrup produces low-carbon earth concrete for construction and urban development. Materrup construction solutions meet the requirements of future RE2020 regulations and the urgent need to reduce the carbon footprint of the construction industry.

Sham Innovation Sante is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Sante's mission is to support innovative businesses in the health care sector through the growth anddevelopment phases of their life cycle.

Investment focus

Biotechnology, Medical Device, Medical
Series B, Series A, Funding Round
France

Portfolio highlights

Cairdac — Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.

Smalt Capital anciennement ACG Management, est un acteur majeur depuis plus de 20 ans

Investment focus

Software, Health Care, Biotechnology
Funding Round, Seed, Series A
France, Madagascar

Portfolio highlights

Kamp'n — Partenaire de croissance Facebook Ads & Google Ads
Little Cigogne — Little Cigogne is reinvents the shopping experience for children.
My Coach Football — My Coach Football allows you to manage and organize the daily operations of your football team, day after day, season after season. Designed to answer amateur and professional coaches’ needs, the platform centralizes all of your squad’s information and allows to gain time and efficiency. In a single click, you can manage players and their personalinformation, the preparation of training and games, but also individual and collective statistics. Season after season, you keep all those data and hence enjoy an optimum tracking of your team’s progression.

Yann sets the vision and strategic direction for Cardiologs and is the guardian of company culture. He is a frequent speaker at industry conferences and is recognized as a thought leader in the application of AI in healthcare. Yann graduated with a degree in Computer Science and Biology from Ecole Polytechnique Paris (X) and the Silicon ValleyInnovation and Entrepreneurship program at UC Berkeley.He was recently named one of MIT Technology Review's Innovators Under 35 in Europe and BNP Paribas European Innovator of the Year. Yann is passionate about the intersection of new technology & clinical practice and is excited to be building a leading company that will help usher in a new era for healthcare worldwide.

Investment focus

Health Care, Medical Device, Artificial Intelligence
Series A, Series B
France

Portfolio highlights

Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
Tilak Healthcare — Tilak is a unique videogame studio where like-minded & passionate people create fun mobile medical games to monitor patients with chronic diseases.
Brink Therapeutics — Brink Therapeutics is a Biotechnology Research firm conducting cell therapy research using reprogrammed recombinases.

The private equity fund focused on adding high value.IXO Private Equity is a private equity management company recognized, approved and authorized by the Financial Market Authorities (AMF) operating under the number GP03018.IXO Private Equity is the most important independent regional private equity General Partner in France.The companymanages French General Private Equity Investment Funds (known in France as F.C.P.R.), Local Private Equity Investment Fund (known in France as F.I.P.), and Private Equity Investment Funds for Innovation (F.C.P.I.) to meet the equity needs for the best companies in Western and Southern France.

Investment focus

Health Care, Manufacturing, Biotechnology
Private Equity, Funding Round, Series A
France, United States, Canada

Portfolio highlights

Indy — Indy offers end-to-end and advanced AI-powered accounting software. Indy is an accounting robot that aims to automate the accounting of freelancers and professionals. It is an accounting robot for the liberal professions. It automates the management of accounting, recovers bank entries to turn them into accounting lines, and sends tax returnsdirectly to an AGM.It was founded in 2016 as Georges by Côme Fouques, Pablo Larvor, Romain Koenig, and Adrien Plat to simplify independent accounting, which is certainly simple but repetitive and time-consuming.
Wecasa — Wecasa is a data-driven marketplace that revolutionizes care services by focusing on user experience for customers and professionalsWecasa's mission is to make care services simple and accessible for a better quality of life. Through its app, users can book in seconds a reliable Professional for care services at home: wellness (haircut,beauty, massage), cleaning, and childcare. Available in Paris, top cities in France, London, and more European cities to come. Wecasa is proud to help 100.000+ customers and increase the business of 3000 independent professionals.
Farmitoo — Farmitoo is an online purchase of farm equipment directly from manufacturers.

Sudinnova is a venture capital firm that invests in information technology, electronics, life sciences, and clean technology sectors.

Investment focus

Software, Biotechnology, Medical
Funding Round, Series A, Seed
France

Portfolio highlights

Kerlink — Founded in 2004, Kerlink is a fast-growing, global and publicly traded provider of Internet of Things (IoT) infrastructure, software and services serving telecom operators, public authorities and businesses of all sizes to design, launch and operate IoT networks.Anticipating a booming market for communication solutions dedicated to connecteddevices, Kerlink founders – William Gouesbet, chairman and CEO, and Yannick Delibie, deputy CEO and CTIO – foresaw the role that RF communication technologies and their associated support platforms could play in M2M vertical segments like fleet management, metering and freight.A co-founder and board member of the LoRa Alliance, Kerlink specialises in end-to-end IoT network solutions for LoRaWAN cost-effective, energy-efficient and long-distance connectivity. The company designed the world’s first commercially available product range of outdoor carrier-grade for IoT dedicated networks.Kerlink also has continuously launched a range of embedded & ruggedized devices and applications for transportation using cellular connectivity, in addition to fleet management and tracking solutions, such as passenger information and entertainment, fuel-efficiency monitoring and car/bike sharing.
Lucibel — Lucibel is an innovative French group that designs and manufactures new-generation lighting products and solutions in France based on LED technology. LED technology is cost efficient, sustainable and smart. It is transforming the world and is now part of the digital era. Not only are Lucibel lighting solutions compatible with remote managementsystems. Light can now interact with its surroundings and be controlled and measured in real time. But it also allows for a new medium for data transmission, interactions and well-being thanks to the development by Lucibel of innovative and smart solutions.
Universign — Have your PDF documents signed online with Universign: the electronic signature and timestamping service recognised by Adobe Reader.

Guillaume Richard is the Founder, Chairman & CEO at Oui Care.He attended EDHEC Business School.

Investment focus

Medical, Software, Health Care
Pre-Seed, Series A
France

Portfolio highlights

HYPNO VR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.

BNP Paribas provides banking, financing, investment, savings, and protection solutions. The Group's three operational divisions are mobilized to support each type of clientele in their growth and development projects including corporate and institutional banking, commercial, personal banking, investment and protection services. The companyprovide financing and investment services to retail customers, associations, businesses, and corporations.

Investment focus

Financial Services, Information Technology, Software
Debt Financing, Funding Round, Post-IPO Debt
France, United Kingdom, United States

Portfolio highlights

Tract'Moi — Tract'Moi is a producer of farming equipment for farmers seeking independence and adaptability.
Zenith Energy — Zenith Energy specialises in tailored remote off-grid power generation and urban microgrids, with a focus on renewable energy generation.
Cypress Creek Renewables — Cypress Creek Renewables is committed to making the world cleaner and healthier. From development to operation, we create and operate valuable solar and storage projects that benefit communities for decades.

Medevice focuses on investing in Medtech and e-health innovation projects. Its team has extensive experience in the fields of medical technology and e-health. The firm is composed of entrepreneurs specialized in healthcare and who have created and/or worked in healthcare companies. This not only allows them to better understand the potentialof the projects presented but also to better support the companies when they face challenges.

Investment focus

Medical Device, Health Care, Medical
Seed, Series A
France

Portfolio highlights

Dyameo — Dyameo develops single-use endoscopic probes for the instant detection of cancer cells.
IMACTIS — IMACTIS is specialized in computer assisted interventional radiology. IMACTIS develops and markets innovative solutions to assist interventional radiologists during minimally invasive needle procedures (biopsies, tumor ablations, vertebroplasties, infiltrations, drainages...). The objective is to increase accuracy and safety, facilitate complexprocedures, reduce the length of procedures, decrease the number of controls and improve patient treatment.

HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide. Beyond its fund, HCVC supports hardtech founders through Hardware Club, a selective global community of 500+ startups with dedicated resources, partnerships and events.

Investment focus

Software, Robotics, Artificial Intelligence
Seed, Series A, Pre-Seed
United States, France, United Kingdom

Portfolio highlights

Karman+ — Mining near Earth asteroids
Fuse Vectors — Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy.
Orakl Oncology — Cultivated with love by the Orakl team.

Bioam Gestion is a venture capital firm that offers a range of credit, insurance, and tax exemption services to its clients.Credit consists of credit repurchase, real estate credit, and consumer credit. Insurance consists of mutual health, life insurance, animal insurance, and prevention. Tax exemption consists of penal law and LMNP.BioamGestion was founded in 2000 and is based in Paris.

Investment focus

Biotechnology, Therapeutics, Health Care
Series B, Seed, Series A
France

Portfolio highlights

TxCell — TxCell, a spin off of Inserm (France's National Institute for Health and Medical Research) located in the technology park of Sophia Antipolis, near Nice in southern France, is developing cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases with high medical need using its unique and proprietary technologyplatform based on the properties of Type 1 regulatory T lymphocytes (Tr1 cells). The company has completed enrollment of a PhI/II study in refractory Crohn's disease patients and has reported first positive results. The company plans to initiate a PhIIb study in the same patient population and bring a second product candidate into a PhI/II study in refractory rheumatoid arthritis patients.
Cytheris — Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation. These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such aschemotherapy, radiotherapy, bone marrow transplantation (BMT) and hematopoietic cell transplantation (HCT).
SuperSonic Imagine — SuperSonic Imagine SA develops and manufactures ultrasound medical imaging systems for measuring and visualizing tissue elasticity. The company provides Aixplorer, an ultrasound system for breast lesion imaging; and ShearWave, an ultrasound technology platform for quantitative elastography. It offers its products through its offices and a networkof distributors in France, Belgium, Austria, Croatia, Poland, the Czech Republic, Singapore, Taiwan, Thailand, Malaysia, Hong Kong, Lebanon, Germany, the United Kingdom, and the United States. SuperSonic Imagine SA was founded in 2005 and is based in Aix-en-Provence, France with additional offices in Germany, the United States, and the United Kingdom.

European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.

Investment focus

Biotechnology, Health Care, Software
Debt Financing, Post-IPO Debt, Funding Round
France, Germany, The Netherlands

Portfolio highlights

Rohlik — Rohlik is an innovative grocery delivery startup that offers a 90-minute same-day delivery service. Since its inception, Rohlik has been growing and is on track to EUR 300 mil. revenues in 2020. Rohlík was founded in 2014 by Marek Sacha and Tomas Cupr and is headquartered in Karlín, Hlavni mesto Praha, Czech Republic.
Eldrive — The largest charging point operator in Eastern Europe | Our network is expanding rapidly yet our focus is fixed on renewables, for a greener future. We provide AC & DC charging across Bulgaria, Romania and Lithuania.
ABN AMRO Bank — Als bank leggen wij de focus op inclusiviteit, duurzaamheid, sociaal ondernemen, innovatie, dagelijkse bankzaken en meer.

Innovacom provides new technologies, hardware, and software products. They focus on the creation of financial and strategic value through support, networking, and the search for the best industrial partners for our startups in a context of open innovation.

Investment focus

Software, Mobile, Telecommunications
Funding Round, Series B, Series A
France, United States, Canada

Portfolio highlights

Samp — Samp accelerates modernization and de-risks contracts by connecting outdated drawings with current 3D reality captures of your facilities using our AI.
Tilkal — Tilkal is the software infrastructure building traceability and transparency for industrial sectors. Combining private blockchain networks and big data, Tilkal organizes an end-to-end, real-time traceability across supply chains for greater control, security and transparency.
Sirfull Technology — Solutions SIRFULL pour le soudage, l'inspection et la maintenance | Welding cloud logiciel soudage | Linspec Cloud logiciel inspection

A Plus Finance, which is headquartered in Paris (France), is an independent trust company specialising in the management of Common Investment Fundsfor Innovation (FCPI) and Proximity Investment Funds (FIP). A Plus Finance is involved in all innovative sectors, particularly in the IT, media and security fields.The A Plus Finance team includesfinanciers and entrepreneurs, thus providing companies with both an awareness of the daily constraints of management and a long-term perspective on the development of their business. Managing funds amounting to nearly â‚¬220m, A Plus Finance invests between â‚¬1 million and â‚¬4 million per project.per

Investment focus

Software, E-Commerce, Telecommunications
Series A, Funding Round, Series B
France, United States

Portfolio highlights

Futura gaia — Futura gaïa is a food production company.
Gaiago — Gaiago is an agtech company that produces soil improvement tools.
La Belle Vie — La Belle Vie is an online grocery based in Paris, France. It sells basic groceries, organic stuff, meat, fish and vegetables. It has developed all its tools from scratch, including its ERP, a warehouse management service and a delivery management service.

Majycc eSanté Invest is an investment firm

Investment focus

Health Care, Fitness, Computer
Seed, Series A, Series B
France

Portfolio highlights

Brightflow — Brightflow operates as a medical device startup.
Archeon — Archeon is fully dedicated to the development of innovative solutions for the monitoring, diagnosis and treatment of critically ill patients in prehospital care.
NaoX Technologies — The tiniest medical grade connected solutions for the prevention of neurological disorders. An EEG On the Go. In-Ear EEG Medical Grade. by Naox Technologies.

Norgine Ventures was started in 2012 to diversify Norgine’s activities and foster innovation in the healthcare sector. Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US. Norgine Ventures is backed by Norgine, a fully integrated, private,European healthcare company with over 110 years of experience in the pharma space.Norgine Ventures has full access to Norgine’s technical capabilities for evaluating investment opportunities, although the business is aimed at achieving a financial return rather than funding opportunities of strategic interest to Norgine.To date, Norgine Ventures has invested in a number of businesses, including specialty pharma, diagnostic and medical device companies, at various stages of their life cycle, both in Europe and in the US.

Investment focus

Health Care, Medical Device, Biotechnology
Funding Round, Debt Financing, Series A
France, United Kingdom, United States

Portfolio highlights

ImaginAb — ImaginAb is a biotechnology company focused on developing a new class of highly targeted diagnostic imaging agents based on engineered antibody fragments. ImaginAb's platform technology enables the rapid engineering of antibodies into fragments that retain the parental antibody but are immunologically passive and kinetically-optimized forclinical imaging. This combination of superior specificity and kinetics enables ImaginAb to generate agents that can address the unmet needs in diagnosis and patient selection for therapeutics.
Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.
Alesi Surgical — Developer of Ultravision, the revolutionary system that clears surgical smoke from the visual field during laparoscopic surgery

Investors by industry

Artificial intelligence